NetMed Transmettre P/E

Quel est le Transmettre P/E de NetMed?

Le Transmettre P/E de NetMed, Inc. est N/A

Quelle est la définition de Transmettre P/E?



Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Que fait NetMed?

Netmed, Inc. did not have any significant operations, as of December 31, 2001. It is evaluating other business opportunities, as of that date. Previously, the company was engaged in the research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company was founded in 1989 and is based in Columbus, Ohio.